table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global IBS-C Drugs Market Size Analysis from 2022 to 2027
1.5.1 Global IBS-C Drugs Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global IBS-C Drugs Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global IBS-C Drugs Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: IBS-C Drugs Industry Impact
Chapter 2 Global IBS-C Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global IBS-C Drugs (Volume and Value) by Type
2.1.1 Global IBS-C Drugs Consumption and Market Share by Type (2016-2021)
2.1.2 Global IBS-C Drugs Revenue and Market Share by Type (2016-2021)
2.2 Global IBS-C Drugs (Volume and Value) by Application
2.2.1 Global IBS-C Drugs Consumption and Market Share by Application (2016-2021)
2.2.2 Global IBS-C Drugs Revenue and Market Share by Application (2016-2021)
2.3 Global IBS-C Drugs (Volume and Value) by Regions
2.3.1 Global IBS-C Drugs Consumption and Market Share by Regions (2016-2021)
2.3.2 Global IBS-C Drugs Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global IBS-C Drugs Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global IBS-C Drugs Consumption by Regions (2016-2021)
4.2 North America IBS-C Drugs Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia IBS-C Drugs Sales, Consumption, Export, Import (2016-2021)
4.4 Europe IBS-C Drugs Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia IBS-C Drugs Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia IBS-C Drugs Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East IBS-C Drugs Sales, Consumption, Export, Import (2016-2021)
4.8 Africa IBS-C Drugs Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania IBS-C Drugs Sales, Consumption, Export, Import (2016-2021)
4.10 South America IBS-C Drugs Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America IBS-C Drugs Market Analysis
5.1 North America IBS-C Drugs Consumption and Value Analysis
5.1.1 North America IBS-C Drugs Market Under COVID-19
5.2 North America IBS-C Drugs Consumption Volume by Types
5.3 North America IBS-C Drugs Consumption Structure by Application
5.4 North America IBS-C Drugs Consumption by Top Countries
5.4.1 United States IBS-C Drugs Consumption Volume from 2016 to 2021
5.4.2 Canada IBS-C Drugs Consumption Volume from 2016 to 2021
5.4.3 Mexico IBS-C Drugs Consumption Volume from 2016 to 2021
Chapter 6 East Asia IBS-C Drugs Market Analysis
6.1 East Asia IBS-C Drugs Consumption and Value Analysis
6.1.1 East Asia IBS-C Drugs Market Under COVID-19
6.2 East Asia IBS-C Drugs Consumption Volume by Types
6.3 East Asia IBS-C Drugs Consumption Structure by Application
6.4 East Asia IBS-C Drugs Consumption by Top Countries
6.4.1 China IBS-C Drugs Consumption Volume from 2016 to 2021
6.4.2 Japan IBS-C Drugs Consumption Volume from 2016 to 2021
6.4.3 South Korea IBS-C Drugs Consumption Volume from 2016 to 2021
Chapter 7 Europe IBS-C Drugs Market Analysis
7.1 Europe IBS-C Drugs Consumption and Value Analysis
7.1.1 Europe IBS-C Drugs Market Under COVID-19
7.2 Europe IBS-C Drugs Consumption Volume by Types
7.3 Europe IBS-C Drugs Consumption Structure by Application
7.4 Europe IBS-C Drugs Consumption by Top Countries
7.4.1 Germany IBS-C Drugs Consumption Volume from 2016 to 2021
7.4.2 UK IBS-C Drugs Consumption Volume from 2016 to 2021
7.4.3 France IBS-C Drugs Consumption Volume from 2016 to 2021
7.4.4 Italy IBS-C Drugs Consumption Volume from 2016 to 2021
7.4.5 Russia IBS-C Drugs Consumption Volume from 2016 to 2021
7.4.6 Spain IBS-C Drugs Consumption Volume from 2016 to 2021
7.4.7 Netherlands IBS-C Drugs Consumption Volume from 2016 to 2021
7.4.8 Switzerland IBS-C Drugs Consumption Volume from 2016 to 2021
7.4.9 Poland IBS-C Drugs Consumption Volume from 2016 to 2021
Chapter 8 South Asia IBS-C Drugs Market Analysis
8.1 South Asia IBS-C Drugs Consumption and Value Analysis
8.1.1 South Asia IBS-C Drugs Market Under COVID-19
8.2 South Asia IBS-C Drugs Consumption Volume by Types
8.3 South Asia IBS-C Drugs Consumption Structure by Application
8.4 South Asia IBS-C Drugs Consumption by Top Countries
8.4.1 India IBS-C Drugs Consumption Volume from 2016 to 2021
8.4.2 Pakistan IBS-C Drugs Consumption Volume from 2016 to 2021
8.4.3 Bangladesh IBS-C Drugs Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia IBS-C Drugs Market Analysis
9.1 Southeast Asia IBS-C Drugs Consumption and Value Analysis
9.1.1 Southeast Asia IBS-C Drugs Market Under COVID-19
9.2 Southeast Asia IBS-C Drugs Consumption Volume by Types
9.3 Southeast Asia IBS-C Drugs Consumption Structure by Application
9.4 Southeast Asia IBS-C Drugs Consumption by Top Countries
9.4.1 Indonesia IBS-C Drugs Consumption Volume from 2016 to 2021
9.4.2 Thailand IBS-C Drugs Consumption Volume from 2016 to 2021
9.4.3 Singapore IBS-C Drugs Consumption Volume from 2016 to 2021
9.4.4 Malaysia IBS-C Drugs Consumption Volume from 2016 to 2021
9.4.5 Philippines IBS-C Drugs Consumption Volume from 2016 to 2021
9.4.6 Vietnam IBS-C Drugs Consumption Volume from 2016 to 2021
9.4.7 Myanmar IBS-C Drugs Consumption Volume from 2016 to 2021
Chapter 10 Middle East IBS-C Drugs Market Analysis
10.1 Middle East IBS-C Drugs Consumption and Value Analysis
10.1.1 Middle East IBS-C Drugs Market Under COVID-19
10.2 Middle East IBS-C Drugs Consumption Volume by Types
10.3 Middle East IBS-C Drugs Consumption Structure by Application
10.4 Middle East IBS-C Drugs Consumption by Top Countries
10.4.1 Turkey IBS-C Drugs Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia IBS-C Drugs Consumption Volume from 2016 to 2021
10.4.3 Iran IBS-C Drugs Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates IBS-C Drugs Consumption Volume from 2016 to 2021
10.4.5 Israel IBS-C Drugs Consumption Volume from 2016 to 2021
10.4.6 Iraq IBS-C Drugs Consumption Volume from 2016 to 2021
10.4.7 Qatar IBS-C Drugs Consumption Volume from 2016 to 2021
10.4.8 Kuwait IBS-C Drugs Consumption Volume from 2016 to 2021
10.4.9 Oman IBS-C Drugs Consumption Volume from 2016 to 2021
Chapter 11 Africa IBS-C Drugs Market Analysis
11.1 Africa IBS-C Drugs Consumption and Value Analysis
11.1.1 Africa IBS-C Drugs Market Under COVID-19
11.2 Africa IBS-C Drugs Consumption Volume by Types
11.3 Africa IBS-C Drugs Consumption Structure by Application
11.4 Africa IBS-C Drugs Consumption by Top Countries
11.4.1 Nigeria IBS-C Drugs Consumption Volume from 2016 to 2021
11.4.2 South Africa IBS-C Drugs Consumption Volume from 2016 to 2021
11.4.3 Egypt IBS-C Drugs Consumption Volume from 2016 to 2021
11.4.4 Algeria IBS-C Drugs Consumption Volume from 2016 to 2021
11.4.5 Morocco IBS-C Drugs Consumption Volume from 2016 to 2021
Chapter 12 Oceania IBS-C Drugs Market Analysis
12.1 Oceania IBS-C Drugs Consumption and Value Analysis
12.2 Oceania IBS-C Drugs Consumption Volume by Types
12.3 Oceania IBS-C Drugs Consumption Structure by Application
12.4 Oceania IBS-C Drugs Consumption by Top Countries
12.4.1 Australia IBS-C Drugs Consumption Volume from 2016 to 2021
12.4.2 New Zealand IBS-C Drugs Consumption Volume from 2016 to 2021
Chapter 13 South America IBS-C Drugs Market Analysis
13.1 South America IBS-C Drugs Consumption and Value Analysis
13.1.1 South America IBS-C Drugs Market Under COVID-19
13.2 South America IBS-C Drugs Consumption Volume by Types
13.3 South America IBS-C Drugs Consumption Structure by Application
13.4 South America IBS-C Drugs Consumption Volume by Major Countries
13.4.1 Brazil IBS-C Drugs Consumption Volume from 2016 to 2021
13.4.2 Argentina IBS-C Drugs Consumption Volume from 2016 to 2021
13.4.3 Columbia IBS-C Drugs Consumption Volume from 2016 to 2021
13.4.4 Chile IBS-C Drugs Consumption Volume from 2016 to 2021
13.4.5 Venezuela IBS-C Drugs Consumption Volume from 2016 to 2021
13.4.6 Peru IBS-C Drugs Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico IBS-C Drugs Consumption Volume from 2016 to 2021
13.4.8 Ecuador IBS-C Drugs Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in IBS-C Drugs Business
14.1 Catalent Pharmaceuticals Solutions
14.1.1 Catalent Pharmaceuticals Solutions Company Profile
14.1.2 Catalent Pharmaceuticals Solutions IBS-C Drugs Product Specification
14.1.3 Catalent Pharmaceuticals Solutions IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Nestle
14.2.1 Nestle Company Profile
14.2.2 Nestle IBS-C Drugs Product Specification
14.2.3 Nestle IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Abbott Laboratories
14.3.1 Abbott Laboratories Company Profile
14.3.2 Abbott Laboratories IBS-C Drugs Product Specification
14.3.3 Abbott Laboratories IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Synergy Pharmaceuticals
14.4.1 Synergy Pharmaceuticals Company Profile
14.4.2 Synergy Pharmaceuticals IBS-C Drugs Product Specification
14.4.3 Synergy Pharmaceuticals IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Sucampo Pharmaceuticals
14.5.1 Sucampo Pharmaceuticals Company Profile
14.5.2 Sucampo Pharmaceuticals IBS-C Drugs Product Specification
14.5.3 Sucampo Pharmaceuticals IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Novartis Pharma Ag
14.6.1 Novartis Pharma Ag Company Profile
14.6.2 Novartis Pharma Ag IBS-C Drugs Product Specification
14.6.3 Novartis Pharma Ag IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Astellas Pharmaceuticals
14.7.1 Astellas Pharmaceuticals Company Profile
14.7.2 Astellas Pharmaceuticals IBS-C Drugs Product Specification
14.7.3 Astellas Pharmaceuticals IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Ardelyx, Inc
14.8.1 Ardelyx, Inc Company Profile
14.8.2 Ardelyx, Inc IBS-C Drugs Product Specification
14.8.3 Ardelyx, Inc IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Synthetic Biologics, Inc
14.9.1 Synthetic Biologics, Inc Company Profile
14.9.2 Synthetic Biologics, Inc IBS-C Drugs Product Specification
14.9.3 Synthetic Biologics, Inc IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Teva Pharmaceutical Industries
14.10.1 Teva Pharmaceutical Industries Company Profile
14.10.2 Teva Pharmaceutical Industries IBS-C Drugs Product Specification
14.10.3 Teva Pharmaceutical Industries IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Bama-Geve, SLU
14.11.1 Bama-Geve, SLU Company Profile
14.11.2 Bama-Geve, SLU IBS-C Drugs Product Specification
14.11.3 Bama-Geve, SLU IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Ferring BV
14.12.1 Ferring BV Company Profile
14.12.2 Ferring BV IBS-C Drugs Product Specification
14.12.3 Ferring BV IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 Ironwood Pharmaceuticals, Inc
14.13.1 Ironwood Pharmaceuticals, Inc Company Profile
14.13.2 Ironwood Pharmaceuticals, Inc IBS-C Drugs Product Specification
14.13.3 Ironwood Pharmaceuticals, Inc IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 Salix Pharmaceuticals Ltd
14.14.1 Salix Pharmaceuticals Ltd Company Profile
14.14.2 Salix Pharmaceuticals Ltd IBS-C Drugs Product Specification
14.14.3 Salix Pharmaceuticals Ltd IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.15 Norgine B.V
14.15.1 Norgine B.V Company Profile
14.15.2 Norgine B.V IBS-C Drugs Product Specification
14.15.3 Norgine B.V IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.16 Prometheus Laboratories Inc
14.16.1 Prometheus Laboratories Inc Company Profile
14.16.2 Prometheus Laboratories Inc IBS-C Drugs Product Specification
14.16.3 Prometheus Laboratories Inc IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.17 Actavis Nordic A/S
14.17.1 Actavis Nordic A/S Company Profile
14.17.2 Actavis Nordic A/S IBS-C Drugs Product Specification
14.17.3 Actavis Nordic A/S IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.18 Albireo Pharma Inc
14.18.1 Albireo Pharma Inc Company Profile
14.18.2 Albireo Pharma Inc IBS-C Drugs Product Specification
14.18.3 Albireo Pharma Inc IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.19 Yuhan Corp
14.19.1 Yuhan Corp Company Profile
14.19.2 Yuhan Corp IBS-C Drugs Product Specification
14.19.3 Yuhan Corp IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.20 Astrazeneca Plc
14.20.1 Astrazeneca Plc Company Profile
14.20.2 Astrazeneca Plc IBS-C Drugs Product Specification
14.20.3 Astrazeneca Plc IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.21 The Menarini Group
14.21.1 The Menarini Group Company Profile
14.21.2 The Menarini Group IBS-C Drugs Product Specification
14.21.3 The Menarini Group IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.22 Ono Pharmaceutical Co., Ltd
14.22.1 Ono Pharmaceutical Co., Ltd Company Profile
14.22.2 Ono Pharmaceutical Co., Ltd IBS-C Drugs Product Specification
14.22.3 Ono Pharmaceutical Co., Ltd IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global IBS-C Drugs Market Forecast (2022-2027)
15.1 Global IBS-C Drugs Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global IBS-C Drugs Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global IBS-C Drugs Value and Growth Rate Forecast (2022-2027)
15.2 Global IBS-C Drugs Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global IBS-C Drugs Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global IBS-C Drugs Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America IBS-C Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia IBS-C Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe IBS-C Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia IBS-C Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia IBS-C Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East IBS-C Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa IBS-C Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania IBS-C Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America IBS-C Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global IBS-C Drugs Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global IBS-C Drugs Consumption Forecast by Type (2022-2027)
15.3.2 Global IBS-C Drugs Revenue Forecast by Type (2022-2027)
15.3.3 Global IBS-C Drugs Price Forecast by Type (2022-2027)
15.4 Global IBS-C Drugs Consumption Volume Forecast by Application (2022-2027)
15.5 IBS-C Drugs Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
